πŸ‡ΊπŸ‡Έ FDA
Patent

US 7384623

High energy phototherapeutic agents

granted A61KA61K41/0038A61K49/0041

Quick answer

US patent 7384623 (High energy phototherapeutic agents) held by Provectus Pharmatech, Inc. expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K41/0038, A61K49/0041